Stroke is a leading cause of mortality and disability worldwide, with approximately 15 million people suffering strokes annually. Machine learning (ML) techniques have emerged as powerful tools for stroke prediction, enabling early identification of risk factors through data-driven approaches. However, the clinical utility and performance characteristics of these approaches require systematic evaluation. To systematically review and analyze ML techniques used for stroke prediction, systematically synthesize performance metrics across different prediction targets and data sources, evaluate their clinical applicability, and identify research trends focusing on patient population characteristics and stroke prevalence patterns. A systematic review was conducted following PRISMA guidelines. Five databases (Google Scholar, Lens, PubMed, ResearchGate, and Semantic Scholar) were searched for open-access publications on ML-based stroke prediction published between January 2013 and December 2024. Data were extracted on publication characteristics, datasets, ML methodologies, evaluation metrics, prediction targets (stroke occurrence vs. outcomes), data sources (EHR, imaging, biosignals), patient demographics, and stroke prevalence. Descriptive synthesis was performed due to substantial heterogeneity precluding quantitative meta-analysis. Fifty-eight studies were included, with peak publication output in 2021 (21 articles). Studies targeted three main prediction objectives: stroke occurrence prediction (n = 52, 62.7 %), stroke outcome prediction (n = 19, 22.9 %), and stroke type classification (n = 12, 14.4 %). Data sources included electronic health records (n = 48, 57.8 %), medical imaging (n = 21, 25.3 %), and biosignals (n = 14, 16.9 %). Systematic analysis revealed ensemble methods consistently achieved highest accuracies for stroke occurrence prediction (range: 90.4-97.8 %), while deep learning excelled in imaging-based applications. African populations, despite highest stroke mortality rates globally, were represented in fewer than 4 studies. ML techniques show promising results for stroke prediction. However, significant gaps exist in representation of high-risk populations and real-world clinical validation. Future research should prioritize population-specific model development and clinical implementation frameworks.

Deep learning (DL) has shown promise in glioma imaging tasks using magnetic resonance imaging (MRI) and histopathology images, yet their complexity demands greater transparency in artificial intelligence (AI) systems. This is noticeable when users must understand the model output for a clinical application. In this systematic review, 65 post-hoc eXplainable AI (XAI), or interpretable AI studies, have been reviewed that provide an understanding of why a system generated a given output for tasks related to glioma imaging. A framework of post-hoc XAI methods, such as Gradient-based XAI (G-XAI) and Perturbation-based XAI (P-XAI), is introduced to evaluate deep models and explain their application in gliomas. The papers on XAI techniques in gliomas are surveyed and categorized by their specific aims such as grading, genetic biomarker detection, localization, intra-tumoral heterogeneity assessment, and survival analysis, and their XAI approach. This review highlights the growing integration of XAI in glioma imaging, demonstrating their role in bridging AI decision-making and medical diagnostics. The co-occurrence analysis emphasizes their role in enhancing model transparency and trust and guiding future research toward more reliable clinical applications. Finally, the current challenges associated with DL and XAI approaches and their clinical integration are discussed with an outlook on future opportunities from clinical users' perspectives and upcoming trends in XAI.

Biomedical image classification is of paramount importance in enhancing diagnostic precision and improving patient outcomes across diverse medical disciplines. In recent years, the advent of deep learning methodologies has significantly transformed this domain by facilitating notable advancements in image analysis and classification endeavors. This paper provides a thorough overview of the application of deep learning techniques in biomedical image classification, encompassing various types of healthcare data, including medical images derived from modalities such as mammography, histopathology, and radiology. A detailed discourse on deep learning architectures, including convolutional neural networks (CNNs), recurrent neural networks (RNNs), and advanced models such as generative adversarial networks (GANs), is presented. Additionally, we delineate the distinctions between supervised, unsupervised, and reinforcement learning approaches, along with their respective roles within the context of biomedical imaging. This study systematically investigates 50 deep learning methodologies employed in the healthcare sector, elucidating their effectiveness in various tasks, including disease detection, image segmentation, and classification. It particularly emphasizes models that have been trained on publicly available datasets, thereby highlighting the significant role of open-access data in fostering advancements in AI-driven healthcare innovations. Furthermore, this review accentuates the transformative potential of deep learning in the realm of biomedical image analysis and delineates potential avenues for future research within this rapidly evolving field.

Foundation models (FMs) represent a significant evolution in artificial intelligence (AI), impacting diverse fields. Within radiology, this evolution offers greater adaptability, multimodal integration, and improved generalizability compared with traditional narrow AI. Utilizing large-scale pre-training and efficient fine-tuning, FMs can support diverse applications, including image interpretation, report generation, integrative diagnostics combining imaging with clinical/laboratory data, and synthetic data creation, holding significant promise for advancements in precision medicine. However, clinical translation of FMs faces several substantial challenges. Key concerns include the inherent opacity of model decision-making processes, environmental and social sustainability issues, risks to data privacy, complex ethical considerations, such as bias and fairness, and navigating the uncertainty of regulatory frameworks. Moreover, rigorous validation is essential to address inherent stochasticity and the risk of hallucination. This international collaborative effort provides a comprehensive overview of the fundamentals, applications, opportunities, challenges, and prospects of FMs, aiming to guide their responsible and effective adoption in radiology and healthcare.

In recent years, hip arthroscopy has made great progress and has been extended to the treatment of intra-articular or periarticular diseases. However, the complex structure of the hip joint, high technical operation requirements and relatively long learning curve have hindered the popularization and development of hip arthroscopy in China. Therefore, on the one hand, it is necessary to promote the research and training of standardized techniques for the diagnosis of hip disease and the treatment of arthroscopic surgery, so as to improve the safety, effectiveness and popularization of the technology. On the other hand, our organization proactively leverages cutting-edge digitalization and intelligentization technologies, including medical image digitalization, medical big data analytics, artificial intelligence, surgical navigation and robotic control, virtual reality, telemedicine, and 5G communication technology. We conduct a range of innovative research and development initiatives such as intelligent-assisted diagnosis of hip diseases, digital preoperative planning, surgical intelligent navigation and robotic procedures, and smart rehabilitation solutions. These efforts aim to facilitate a digitalization and intelligentization leap in technology and continuously enhance the precision of diagnosis and treatment. In conclusion, standardization promotes the homogenization of diagnosis and treatment, while digitalization and intelligentization facilitate the precision of operations. The synergy of the two lays the foundation for personalized diagnosis and treatment and continuous innovation, ultimately driving the rapid development of hip arthroscopy technology.

Idiopathic inflammatory myopathies (IIM) are a group of autoimmune rheumatic diseases characterized by proximal muscle weakness and extra muscular manifestations. Since 1975, these IIM have been classified into different clinical phenotypes. Each clinical phenotype is associated with a better or worse prognosis and a particular physiopathology. Machine learning (ML) is a fascinating field of knowledge with worldwide applications in different fields. In IIM, ML is an emerging tool assessed in very specific clinical contexts as a complementary tool for research purposes, including transcriptome profiles in muscle biopsies, differential diagnosis using magnetic resonance imaging (MRI), and ultrasound (US). With the cancer-associated risk and predisposing factors for interstitial lung disease (ILD) development, this systematic review evaluates 23 original studies using supervised learning models, including logistic regression (LR), random forest (RF), support vector machines (SVM), and convolutional neural networks (CNN), with performance assessed primarily through the area under the curve coupled with the receiver operating characteristic (AUC-ROC).

The aim of the present article is to enrich the comprehension of iterative magnetic resonance imaging (MRI) reconstructions, including compressed sensing (CS) and iterative deep learning (DL) reconstructions, by describing them in the general framework of finite-dimensional inner-product spaces. In particular, we show that image-space preconditioning (ISP) and data-space preconditioning (DSP) can be formulated as non-conventional inner-products. The main gain of our reformulation is an embedding of ISP in the variational formulation of the MRI reconstruction problem (in an algorithm-independent way) which allows in principle to naturally and systematically propagate ISP in all iterative reconstructions, including many iterative DL and CS reconstructions where preconditioning is lacking. The way in which we apply linear algebraic tools to MRI reconstructions as presented in this article is a novelty. A secondary aim of our article is to offer a certain didactic material to scientists who are new in the field of MRI reconstruction. Since we explore here some mathematical concepts of reconstruction, we take that opportunity to recall some principles that may be understood for experts, but which may be hard to find in the literature for beginners. In fact, the description of many mathematical tools of MRI reconstruction is fragmented in the literature or sometimes missing because considered as a general knowledge. Further, some of those concepts can be found in mathematic manuals, but not in a form that is oriented toward MRI. For example, we think of the conjugate gradient descent, the notion of derivative with respect to non-conventional inner products, or simply the notion of adjoint. The authors believe therefore that it is beneficial for their field of research to dedicate some space to such a didactic material.

Quantitative imaging (QI) is demonstrating strong promise across multiple clinical applications. For clinical translation of QI methods, objective evaluation on clinically relevant tasks is essential. To address this need, multiple evaluation strategies are being developed. In this paper, based on previous literature, we outline four emerging frameworks to perform evaluation studies of QI methods. We first discuss the use of virtual imaging trials (VITs) to evaluate QI methods. Next, we outline a no-gold-standard evaluation framework to clinically evaluate QI methods without ground truth. Third, a framework to evaluate QI methods for joint detection and quantification tasks is outlined. Finally, we outline a framework to evaluate QI methods that output multi-dimensional parameters, such as radiomic features. We review these frameworks, discussing their utilities and limitations. Further, we examine future research areas in evaluation of QI methods. Given the recent advancements in PET, including long axial field-of-view scanners and the development of artificial-intelligence algorithms, we present these frameworks in the context of PET.

The aim of the present article is to enrich the comprehension of iterative magnetic resonance imaging (MRI) reconstructions, including compressed sensing (CS) and iterative deep learning (DL) reconstructions, by describing them in the general framework of finite-dimensional inner-product spaces. In particular, we show that image-space preconditioning (ISP) and data-space preconditioning (DSP) can be formulated as non-conventional inner-products. The main gain of our reformulation is an embedding of ISP in the variational formulation of the MRI reconstruction problem (in an algorithm-independent way) which allows in principle to naturally and systematically propagate ISP in all iterative reconstructions, including many iterative DL and CS reconstructions where preconditioning is lacking. The way in which we apply linear algebraic tools to MRI reconstructions as presented in this article is a novelty. A secondary aim of our article is to offer a certain didactic material to scientists who are new in the field of MRI reconstruction. Since we explore here some mathematical concepts of reconstruction, we take that opportunity to recall some principles that may be understood for experts, but which may be hard to find in the literature for beginners. In fact, the description of many mathematical tools of MRI reconstruction is fragmented in the literature or sometimes missing because considered as a general knowledge. Further, some of those concepts can be found in mathematic manuals, but not in a form that is oriented toward MRI. For example, we think of the conjugate gradient descent, the notion of derivative with respect to non-conventional inner products, or simply the notion of adjoint. The authors believe therefore that it is beneficial for their field of research to dedicate some space to such a didactic material.

Abbreviated breast MRI protocols are advocated for breast screening as they limit acquisition duration and increase resource availability. However, radiologists' specificity may be slightly lowered when only such short protocols are evaluated. An adaptive approach, where a full protocol is performed only when abnormalities are detected by artificial intelligence (AI)-based models in the abbreviated protocol, might improve and speed up MRI screening. This study explores the potential benefits of such an approach. To assess the potential impact of adaptive breast MRI scanning based on AI detection of malignancies. Mathematical model. Breast cancer screening protocols. Theoretical upper and lower limits on expected protocol duration and recall rate were determined for the adaptive approach, and the influence of the AI model and radiologists' performance metrics on these limits was assessed, under the assumption that any finding on the abbreviated protocol would, in an ideal follow-up scenario, prompt a second MRI with the full protocol. Estimated most likely scenario. Theoretical limits for the proposed adaptive AI-based MRI breast cancer screening showed that the recall rates of the abbreviated and full screening protocols always constrained the recall rate. These abbreviated and full protocols did not fully constrain the expected protocol duration, and an adaptive protocol's expected duration could thus be shorter than the abbreviated protocol duration. Specificity, either from AI models or radiologists, has the largest effect on the theoretical limits. In the most likely scenario, the adaptive protocol achieved an expected protocol duration reduction of ~47%-60% compared with the full protocol. The proposed adaptive approach may offer a reduction in expected protocol duration compared with the use of the full protocol alone, and a lower recall rate relative to an abbreviated-only approach could be achieved. Optimal performance was observed when AI models emulated radiologists' decision-making behavior, rather than focusing solely on near-perfect malignancy detection. Not applicable. Stage 6.